Centerline Biomedical Reports the US FDA’s Approval of its IOPS Viewpoint Catheter
Shots:
- The US FDA has granted 510(k) clearance to the company's IOPS Viewpoint Catheter, which reduces physician and patient exposure to harmful X-rays at the time of image-guided, endovascular procedures
- The catheter offers 3D navigation feedback for precision access and enables real-time visualization of endovascular tools when combined with IOPS software, reducing reliance on fluoroscopy and harmful radiation exposure during endovascular procedures
- The device improves visualization, minimizes procedure times, and decreases radiation exposure for patients & healthcare providers
Click here to read the full press release
Tags
Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.
